Which has the lower trailing P/E, TEVA or WAT?

TEVA has the lower trailing P/E: TEVA trades at 65.87 and WAT at 106.17. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, TEVA or WAT?

Over the past five years, WAT grew revenue faster — TEVA at a 1.19% CAGR versus WAT at 11.70%.

Is TEVA or WAT more profitable?

TEVA runs the higher net margin — TEVA at 4.08% versus WAT at 3.58%.

How have TEVA and WAT total returns compared?

Over the past 10 years, TEVA delivered -2.58% and WAT delivered 10.36% annualized total return. Past performance doesn't predict future results.

Teva Pharmaceutical Industries Limited (TEVA) vs Waters Corporation (WAT)

A side-by-side comparison of Teva Pharmaceutical Industries Limited and Waters Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

TEVA

Teva Pharmaceutical Industries Limited

$46.03B

$39.52HealthcareDelayed quote: Sep 22, 2026, 4:00 PM EDT

WAT

Waters Corporation

$41.80B

$425.74HealthcareDelayed quote: Sep 22, 2026, 4:00 PM EDT

Total return — TEVA vs WAT

growth of $100 · dividends reinvested · last 10y

TEVA -25.2% (-2.9%/yr)WAT +161.7% (+10.1%/yr)WAT compounded faster over this window

TEVA WAT

TEVA vs WAT: by the numbers

•TEVA is the larger company ($46.03B vs $41.80B market cap).
•TEVA trades at the lower trailing earnings multiple (65.87 vs 106.17 P/E), one valuation lens rather than an overall verdict.
•TEVA converts more revenue to profit (4.08% vs 3.58% net margin).
•WAT grew revenue faster over the past five years (11.70% vs 1.19% CAGR).

Metrics side by side

Valuation

Metric	TEVA	WAT
P/E ratio	65.87	106.17
Forward P/E	19.89	29.21
P/S ratio	2.66	9.00
P/B ratio	5.93	2.75
EV / EBITDA	19.93	50.13
FCF yield	2.93%	0.95%

Profitability

Metric	TEVA	WAT
Gross margin	52.47%	50.78%
Operating margin	11.45%	28.22%
Net margin	4.08%	3.58%
ROE	9.10%	1.09%
ROIC	6.79%	1.34%

Growth (annualized)

Metric	TEVA	WAT
Revenue CAGR (5Y)	1.19%	11.70%
EPS CAGR (5Y)	N/A	5.16%
FCF CAGR (5Y)	14.58%	-9.10%
Total return CAGR (5Y)	32.17%	-0.83%

Frequently asked

Which has the lower trailing P/E, TEVA or WAT?: TEVA has the lower trailing P/E: TEVA trades at 65.87 and WAT at 106.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, TEVA or WAT?: Over the past five years, WAT grew revenue faster — TEVA at a 1.19% CAGR versus WAT at 11.70%.
Is TEVA or WAT more profitable?: TEVA runs the higher net margin — TEVA at 4.08% versus WAT at 3.58%.
How have TEVA and WAT total returns compared?: Over the past 10 years, TEVA delivered -2.58% and WAT delivered 10.36% annualized total return. Past performance doesn't predict future results.

Go deeper

Full TEVA analysis Full WAT analysis Interactive comparison tool

Dig into the metrics

Teva Pharmaceutical Industries P/E ratio Waters P/E ratio Teva Pharmaceutical Industries ROE Waters ROE Teva Pharmaceutical Industries operating margin Waters operating margin Teva Pharmaceutical Industries revenue growth Waters revenue growth Teva Pharmaceutical Industries free cash flow Waters free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.